BridgeBio Pharma, Inc. (BBIO)

Healthcare · Biotechnology · NASDAQ

BridgeBio Pharma, Inc. (BBIO) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $16.55B and a free-cash-flow yield of -2.8%. Over the most recent reported fiscal year, revenue grew 126.3%.

Market cap	$16.55B
Trailing P/E	—
FCF yield	-2.8%
Revenue growth (YoY)	+126.3%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live BBIO data on Nama Insights →

Recent Congressional trades

BridgeBio Pharma, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Jun 5, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Apr 6, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Oct 8, 2025
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Sep 8, 2025